11月13日，华侨城A发布2025年10月主要业务经营情况公告。 公告显示，2025 年10月，公司实现合同销售面积9.1万平方米，同比减少62%，环比9月增加16%；合同 销售金额13.0亿元，同比减少57%，环比9月增加20%。 2025年1-10 月，公司累计实现合同销售面积98.4万平方米，同比减少26%；合同销售金额145.5亿元，同 比减少27%。 2025年10月，公司旗下文旅企业合计接待游客746万人次，同1比下降7%，主要是"惊奇潮玩节"等部分 节日活动整体消费热度有所回落。2025年1-10月，公司旗下文旅企业合计接待游客6701万人次，同比下 降2%。 ...

据悉，正定真悦天地的商业部分计划于2027年1月前正式开业。 正定真悦天地商业板块面积约10万平方米，涵盖商业MALL与特色街区相结合的全新形态，约有35%的 品牌商户将作为京津冀区域首店亮相。 据悉，正定真悦天地的商业部分计划于2027年1月前正式开业。 11月13日，据融创官微消息，近日，融创商业与河北深国际真悦天地置业发展有限公司达成合作意向， 将全面承接正定真悦天地商业板块的招商运营管理。 ...

Core Insights - The company reported a 59.8% year-on-year increase in total revenue for the first three quarters of 2025, reaching 1.12 billion RMB, driven by the continued growth in sales of its core product, BTK inhibitor Oubatinib (Yinokai®), and an upfront payment from a licensing agreement with Prolium [1] Revenue Performance - Oubatinib's revenue for the first three quarters increased by 45.8% year-on-year, amounting to 1.01 billion RMB, surpassing the total revenue of the previous year, attributed to the expanding market for its exclusive indication of marginal zone lymphoma (MZL) and the approval of new indications for first-line treatment of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) [1] Loss Reduction - The company's losses significantly narrowed by 74.8%, reducing to 0.07 billion RMB, primarily due to rapid revenue growth and improved cost efficiency [1]

Core Insights - Eddycon Holdings announced the signing of a definitive share purchase agreement to acquire all issued shares of Crown Bioscience International for a base consideration of $204 million, which includes performance-based payments [1] - The transaction is expected to be completed by mid-2026, with adjustments based on customary post-closing conditions [1] - Crown Bioscience is a global contract research organization (CRO) focused on drug discovery, preclinical, and translational research, particularly in oncology and immuno-oncology [1] Company Strategy - The acquisition aims to leverage the growing demand for precision diagnostics in China and the global biopharmaceutical innovation trends, presenting dual growth opportunities for Eddycon [1] - Post-acquisition, Crown Bioscience will operate as an independent entity under Eddycon, maintaining its research leadership and global client relationships while utilizing Eddycon's resources for further development [1] Financial Details - The total purchase price of $204 million includes a one-time profit payment of up to $40 million and a second profit payment of up to $44 million, contingent on the target group's adjusted EBITDA [1]

Core Insights - Tencent Holdings reported Q3 2025 revenue of 192.9 billion yuan, a 15% year-on-year increase [1] - Non-IFRS operating profit for Q3 was 72.57 billion yuan, up 18% year-on-year [1] Revenue Breakdown - Value-added services revenue reached 95.9 billion yuan, growing 16% year-on-year [1] - Online gaming revenue totaled 63.6 billion yuan, with international market revenue increasing by 43% to 20.8 billion yuan, driven by Supercell games and new releases [1] - Domestic gaming revenue was 42.8 billion yuan, a 15% increase, supported by new game launches and existing titles like "Honor of Kings" [1] Social Network and Marketing Services - Social network revenue was 32.3 billion yuan, up 5% year-on-year, attributed to growth in video live streaming and music subscription services [1] - Marketing services revenue for Q3 was 36.2 billion yuan, a 21% increase, driven by higher ad exposure and AI-driven ad targeting improvements [1] Financial Technology and Enterprise Services - Financial technology and enterprise services revenue reached 58.2 billion yuan, a 10% year-on-year increase, with growth in merchant payment activities and consumer loan services [2] - Enterprise services revenue grew by over 10%, benefiting from cloud service revenue and increased transaction volumes in WeChat stores [2] R&D Investment - R&D expenditure for Q3 increased by 28% to 22.8 billion yuan, marking a record high for a single quarter [2] - As of the end of the quarter, Tencent had over 91,000 patent applications published globally, with more than 50,000 patents granted [2]

11月13日，五矿地产发布公告，何剑波因中国五矿集团有限公司的人员轮换与继任规划安排而辞任公司 执行董事、董事会主席、董事会辖下的执行委员会、提名委员会及可持续发展委员会主席及薪酬委员会 成员、授权代表的职务，由2025年11月13日起生效。 同时，公司执行董事兼董事总经理戴鹏宇已获委任为董事会代理主席、董事会辖下的执行委员会、提名 委员会及可持续发展委员会代理主席、薪酬委员会成员及授权代表，自2025年11月13日起生效，直至正 式委任新董事会主席为止。 直至正式委任新董事会主席为止。 ...

Group 1 - The core viewpoint of the articles highlights the rapid expansion of the ETF market in China, with total scale reaching approximately 5.74 trillion yuan, marking a year-on-year increase of over 53.96% [2][4][5] - The growth of ETFs is driven by a favorable market environment and increasing recognition of passive index investing among various investors, leading to significant inflows into thematic and industry-specific ETFs [2][3] - The number of newly launched ETFs in 2023 has reached a historical high, with 318 new products and nearly 2.5 billion units issued, contributing to the overall growth of the ETF market [4][5] Group 2 - The competition in the ETF industry is intensifying, with a shift from scale expansion to enhancing investor education and comprehensive service levels, focusing on improving investor experience [1][2][6] - Fund companies are encouraged to adopt a three-dimensional system that integrates product, service, and operation to build long-term competitive advantages and transition from homogeneous competition to differentiated value competition [1][8] - New players are entering the ETF market, with established firms like Changcheng Fund and Xingsheng Global Fund launching ETF products, indicating a dynamic and competitive landscape [8][9] Group 3 - The ETF market is witnessing a structural differentiation, with broad-based ETFs experiencing some redemptions while thematic products aligned with market trends are gaining popularity [2][4] - The industry is seeing a rise in innovative ETF products, including cross-market and multi-asset ETFs, to meet diverse investor needs and preferences [9] - The focus on educating investors about the nature of ETFs as asset allocation tools is crucial, emphasizing their risk diversification capabilities while also addressing the volatility associated with index tracking [3][6]

富达基金年内连续增资并非个例，而是外资机构加码中国市场的缩影。2025年以来，摩根士丹利基金、 联博基金上调了注册资本。 3月，联博基金发布公告称，经股东联博香港有限公司决定，联博基金管理有限公司的注册资本由原来 的3亿元增加至5亿元。公司由联博香港有限公司全资控股，本次增加注册资本后，股东持股比例不变。 联博香港有限公司在2024年已经实施过增资。 4月，外资公募摩根士丹利基金管理（中国）有限公司完成了工商变更，注册资本从6亿元人民币增加至 9.5亿元人民币，增幅达到58%。此次增资完成后，公司注册资本达到9.5亿元人民币，由摩根士丹利国 际控股公司全资持股。 近日，外商独资公募富达基金发生工商变更，注册资本由1.82亿美元增至2亿美元。 这已是富达基金年内第二次增资。今年2月份，富达基金的注册资本由1.6亿美元增加至1.82亿美元，彰 显了其股东富达国际对中国资本市场的长期信心与战略投入决心。 富达基金表示，中国是富达全球战略的重要组成部分，希望长期扎根中国市场，为中国客户提供世界一 流的投资解决方案和服务。 截至2025年三季度末，富达基金已构建起覆盖股票型、混合型、债券型及公募 FOF 的多元化产品矩 ...

作者丨彭鑫 编辑丨安安 11月3日凌晨，安徽奇瑞汽车销售有限公司发布天门山挑战测试意外情况的致歉声明。 声明显示，2025年11月12日12时，风云X3L在湖南张家界天门山景区进行的极限挑战测试项目中，因突 发意外导致测试中断，并引发了广泛关注。 图源：奇瑞汽车官方微博 在此，我们向天门山景区、游客、合作伙伴及所有关心此事的朋友们致以最诚挚的歉意。经初步调查核 实，此事故的直接原因是，测试装置的安全防护绳固定点卸扣意外脱落，进而导致防护绳缠绕右侧车 轮，动力输出受阻，车辆下滑撞击护栏，造成部分护栏受损。所幸本次意外未造成人员受伤以及自然环 境的破坏。对于此次测试造成的天门山场地损失，我们深表歉意，承诺将全力修复并承担赔偿责任，做 好所有善后工作。 据经济日报报道，10月12日，多名网友发布视频显示，湖南张家界天门山国家森林公园景区，一辆汽车 在"天梯"上进行爬台阶挑战，结果从台阶上溜下，还撞坏了护栏。 公开资料显示，天门山"天梯"全长近300米，垂直落差150米，共有999级台阶，是通往天门洞的主要途 径。有网友认为，把游客走的"天梯"腾给汽车做测试，不但影响了游客的旅游体验，还对景区设施造成 了破坏。天门山 ...

11月12日，中银理财发布公告称，为保护投资者的权益，根据《中银理财-稳汇固收增强（美元年年开）03期产品说明书》"八、提前终止"的相关约定，该 公司作为"中银理财-稳汇固收增强（美元年年开）03期"（产品代码：ZYWHZQNNK003）产品管理人决定于2025年11月19日提前终止该产品，2025年11月 19日当日，暂停产品的申购和赎回业务。 ...